Amended and Restated Employment Agreement - Jay M. Gellert



 EXHIBIT 10.3 
 Jay M. Gellert 
 AMENDED AND RESTATED 
 EMPLOYMENT AGREEMENT 
 This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this
“Agreement”) is made and entered into as of February 23, 2007 (the “Effective Date”) and amended and restated as of December 3, 2008, by and between Health Net, Inc., a Delaware corporation (the “Company”),
with its principal place of business located at 21650 Oxnard Street, Woodland Hills, California 91367, and Jay M. Gellert (“Executive”). 
 RECITALS 
 WHEREAS, the Company desires to continue Executive’s employment in the capacity as
President and Chief Executive Officer; and 
 WHEREAS, the Company and Executive desire to amend and restate the Agreement to satisfy the
requirements of Section 409A of the Internal Revenue Code of 1986, as amended and the Treasury Regulations and Internal Revenue Service guidance thereunder (“Section 409A”); and 
 WHEREAS, this Agreement is intended to amend and restate in its entirety the Letter Agreement, dated August 22, 1997, the Letter Agreement dated
March 2, 2000, the Agreement dated January 1, 2001, the Letter Agreement dated October 13, 2002, and the Agreement dated February 23, 2007 by and between Executive and the Company, relating to Executive’s employment with the
Company (collectively, the “Prior Employment Agreement”). 
 NOW, THEREFORE, in consideration of the following covenants,
conditions and promises contained herein, and other good and valuable consideration, the Company and Executive hereby agree as follows: 
 1.
Duties and Salary. 
 A. Duties. Executive’s title is President and Chief Executive Officer, but may be changed at the
discretion of the Board of Directors of the Company (the “Board”) to a title that reflects a similarly situated senior executive position. Executive shall report directly to the Board, but Executive’s reporting relationship may be
changed from time to time at the discretion of the Board. Executive’s duties and responsibilities are to provide executive leadership and management of the Company, but the Board reserves the right to assign Executive other duties as needed and
to change Executive’s duties from time to time on reasonable notice, based on Executive’s skills and the needs of the Company. 
 B. Salary. Executive will be paid an annual base salary of $1,200,000, which salary will be paid on a pro-rated bi-weekly basis, less applicable withholdings (“Base Salary”), covering all hours worked, but the Board may
change Executive’s compensation from time-to-time. 

  

 - 1 - 








 
Pursuant to the charter of the Compensation Committee of the Company’s Board of Directors (the “Committee”), Executive’s Base Salary will
be reviewed annually. Any adjustment to Executive’s compensation must be made with the approval of the Committee and with the ratification of the independent directors of the Board. 
 C. Disclosure of Personal Compensation Information. As an “executive officer” of the Company (as such term is defined in the rules and
regulations of the Securities and Exchange Commission (“SEC”)), information regarding Executive’s employment arrangements with the Company, including, among other things, the terms of this Agreement and any stock option agreement,
restricted stock agreement, restricted stock unit agreement and/or severance agreement Executive enters into with the Company from time to time (collectively, “Personal Compensation Information”), may be disclosed in filings with the SEC,
the New York Stock Exchange (“NYSE”) and/or other regulatory organizations upon the occurrence of certain triggering events. Such triggering events include, but are not limited to, the execution of this Agreement and any amendments
thereto, changes in Executive’s Base Salary, any annual incentive payment (whether in the form of cash or equity) awarded to Executive (in the past or after the date hereof), and the establishment of performance goals under the Company’s
incentive plans. Executive’s execution of this Agreement will serve as Executive’s acknowledgement that Executive’s Personal Compensation Information may be publicly disclosed from time to time in filings with the SEC, NYSE or
otherwise as required by applicable law. 
 2. Adjustments and Changes in Employment Status. Executive understands that the Board may
make personnel decisions regarding Executive’s employment, including, but not limited to, decisions regarding any salary adjustment, transfer or disciplinary action, up to and including termination, consistent with the needs of the business of
the Company. 
 3. Protection of Proprietary and Confidential Information. Executive agrees that Executive’s employment creates a
relationship of confidence and trust with the Company with respect to Proprietary and Confidential Information (as defined below) of the Company learned by Executive during Executive’s employment. 
 A. Executive agrees not to directly or indirectly use or disclose any of the Proprietary and Confidential Information of the Company or any of its
affiliates at any time except in connection with the services Executive provides to such entities. “Proprietary and Confidential Information” shall mean trade secrets, confidential knowledge, data or any other proprietary or
confidential information of the Company or any of its affiliates, or of any customers, members, employees or directors of any of such entities, but shall not include any information that (i) was publicly known and made generally available in
the public domain prior to the time of disclosure to Executive by the Company or (ii) becomes publicly known and made generally available after disclosure to Executive by the Company other than as a result of a disclosure by Executive in
violation of this Agreement. By way of illustration but not limitation, “Proprietary and Confidential Information” includes: (i) trade secrets, documents, memoranda, reports, files, correspondence, lists and other written and graphic
records affecting or relating to any such entity’s business; (ii) confidential marketing information including without limitation marketing strategies, customer and client names and requirements, services, prices, margins and costs;
(iii) confidential financial information; (iv) personnel information (including without limitation employee compensation); and (v) other confidential business information. 
  

 - 2 - 








 B. Executive further agrees that at all times during Executive’s employment and thereafter,
Executive will keep in confidence and trust all Proprietary and Confidential Information, and that Executive will not use or disclose any Proprietary and Confidential Information or anything related to such information without the written consent of
the Company, except as may be necessary in the ordinary course of performing Executive’s duties to the Company. 
 C. All Company
property, including, but not limited to, Proprietary and Confidential Information, documents, data, records, apparatus, equipment and other physical property, whether or not pertaining to Proprietary and Confidential Information, provided to
Executive by the Company or any of its affiliates or produced by Executive or others in connection with Executive’s providing services to the Company or any of its affiliates shall be and remain the sole property of the Company or its
affiliates (as the case may be) and shall be returned promptly to such appropriate entity as and when requested by such entity. Executive shall return and deliver all such property upon termination of Executive’s employment, and Executive may
not take any such property or any reproduction of such property upon such termination. 
 D. Executive recognizes that the Company and its
affiliates have received and in the future will receive information from third parties which is private, proprietary or confidential information subject to a duty on such entity’s part to maintain the confidentiality of such information and to
use it only for certain limited purposes. Executive agrees that during Executive’s employment, and thereafter, Executive owes such entities and such third parties a duty to hold all such private, proprietary or confidential information received
from third parties in the strictest confidence and not to disclose it, except as necessary in carrying out Executive’s work for such entities consistent with such entities’ agreements with such third parties, and not to use it for the
benefit of anyone other than for such entities or such third parties consistent with such entities’ agreements with such third parties. 
 E. Executive’s obligations under this Section 3 shall continue after the termination of Executive’s employment and any breach of this Section 3 shall be a material breach of this Agreement. 
 4. Physical Exam. Executive will be required, on an annual basis, to undergo a physical examination and to send evidence that Executive has
undergone such exam (but in no case the results of such exam) to the Senior Vice President of Organizational Effectiveness. The Company shall reimburse Executive for any out-of-pocket expenses relating to the physical examination that are not
otherwise covered by Executive’s health insurance plan. 
 5. Representations and Warranties of Executive. 
 A. No Violation; No Conflicts. Executive represents and warrants to the Company that the entering into of this Agreement and Executive’s
performance of Executive’s duties hereunder, will not violate any agreements with, or trade secrets of, any other person or entity. Executive further represents and warrants that Executive does not have any relationship or commitment to any
other person or entity that might be in conflict with Executive’s obligations to the Company under this Agreement, including but not limited to outside employment, sales broker relationships, investments or business activities. Executive
understands and agrees that 

  

 - 3 - 








 
while employed by the Company Executive is expected to refrain from engaging in any outside activities that might be in conflict with the business interests
of the Company. In addition, Executive represents and warrants to the Company that Executive has not shared with or disclosed to, and will not share with or disclose to, the Company any proprietary or confidential information of Executive’s
previous employers or any other third party. 
 B. Legal Proceedings. Executive represents and warrants to the Company that Executive
has not been arrested, indicted, convicted or otherwise involved in any criminal or civil action or legal matter that could affect Executive’s ability to perform Executive’s duties hereunder or that may have a negative impact on the
Company, its reputation or its operations. Executive agrees, to the extent permitted by applicable law, to notify the Board immediately in the event that Executive becomes party to any criminal or civil action or other legal matter in the future
that could have an affect on the foregoing representation. 
 6. Executive Benefits. 
 A. Employee Benefit Programs. Executive is eligible to participate in the Company’s various employee benefit programs and plans in place from
time to time as long as Executive remains employed by the Company and Executive meets the applicable participation requirements. These benefit programs and plans include paid time off, which shall not be less than 22 days per calendar year
(“PTO”), holidays, group medical, dental, vision, term life, and short and long term disability insurance and participation in the Company's 401(k) plan, tuition reimbursement plan, deferred compensation plan and Supplemental Executive
Retirement Plan. The Company or its subsidiaries or affiliates may modify, terminate or amend any benefit or plan in its discretion, retroactively or prospectively, subject only to applicable law. 
 B. Required Insurance. Executive is covered by workers’ compensation insurance and state disability insurance, as required by state law.

 C. Financial Counseling Allowance. Executive is entitled to be reimbursed up to the amount of $5,000 (net of taxes) per year for
documented costs incurred for personal financial counseling services provided to Executive, including tax preparation, as long as Executive remains employed by the Company. 
 D. Incentive Bonus. Executive is eligible to participate in the Health Net, Inc. Executive Incentive Plan (“EIP”) in accordance with the
terms of the EIP, which provides Executive with a target opportunity to earn each plan year up to 125% of Executive’s Base Salary as additional compensation according to the terms of the actual EIP documents. The bonus payment will range from
0% to 200% of target depending upon the actual results achieved, and specific, individually tailored measures will be established by the Company that must be achieved by Executive in order for Executive to be eligible to receive bonus payments for a
given plan year. It is understood that the Committee and the Company will award bonus amounts, if any, as it deems appropriate consistent with the guidelines of the EIP. 
 E. Housing/Relocation. The Company will provide Executive, at its expense, with housing, including the use of utilities, in Woodland Hills, California, at a reasonable monthly cost. Weekend trips to
Executive’s residence in San Francisco will be at the Company’s expense. Any modification to the housing provided Executive in Woodland Hills, California, 

  

 - 4 - 








 
must be approved in advance by the Committee. In addition, the Committee may review and modify such housing arrangements in its sole discretion from time to
time. Executive may, at Executive’s option, decide to relocate to Southern California. Should Executive decide to relocate, the Company will provide Executive with certain benefits to assist Executive in relocating to Woodland Hills, including:
(i) payment for all packing, shipping and unloading of all Executive’s reasonable household items upon Executive’s move and up to 60 days storage of such items; and (ii) assistance with the sale of Executive’s current home
to include payment of up to a 7% real estate commission, and assistance in the purchase of a new home to include payment of up to two points with respect to financing of such home and Federal and state tax gross-ups on the above items, as allowed by
law. 
 F. Expenses. Subject to and in accordance with the Company's written policies for business and travel expenses, Executive will
receive reimbursement for all business travel and other out-of-pocket expenses reasonably incurred by Executive in the performance of Executive’s duties pursuant to this Agreement. 
 G. Company Car. The Company will provide Executive with the use of an automobile, the type and cost of which must be approved by the Committee.
All expenses associated with Executive’s personal use of such automobile will be deemed to be imputed income to Executive and will be “grossed-up” for income tax purposes at the applicable federal and state income tax level.

 H. Miscellaneous. Executive is entitled to a (i) Company provided cell phone and the Company will pay for Executive’s
usage of such phone (ii) fax machine to be installed in Executive’s home and (iii) reimbursement of the cost of the annual physical exam as set forth in Section 4 above. 
 7. Equity Grants. 
 A. Future
Equity Grants. Any future equity grants made to Executive will be granted under one of the Company’s Long-Term Incentive Plans, and will be subject to the terms of such plan and of the agreement executed in connection with such grant. Any
future equity grants to Executive will be made at the discretion of the Committee and with the approval of the independent directors of the Board. 
 B. Company Stock Ownership Requirement. In accordance with the Executive Officer Stock Ownership Policy adopted by the Board of Directors of the Company (the “Executive Stock Ownership Policy”), Executive is required to own
shares of Common Stock of the Company having a value of five times (5x) Executive’s Base Salary in effect from time to time pursuant to this Agreement (the “Stock Ownership Requirement”). The number of shares of Common Stock
Executive is required to own will be calculated based on the average NYSE closing price per share of the Company's Common Stock (as adjusted for stock splits and similar changes to the Common Stock) for the most recently completed fiscal year of the
Company. 
 Using Executive’s current salary of $1,200,000 and a stock price of $45.3450, which is the average closing price per share
of the Company’s Common Stock as of December 31, 2006, Executive’s current stock ownership requirement is 132,319 (“Target Amount”). The Target Amount is subject to change from time to time based on (1) changes in the
average 

  

 - 5 - 








 
closing sales price of the Company’s Common Stock on an annual basis and (2) any changes in Executive’s Base Salary made pursuant to and in
accordance with Section 1B of this Agreement. Any shares of Company Common Stock that Executive owns, and any restricted stock units or shares of restricted stock of the Company that Executive owns and have vested count toward the Target
Amount. Stock options, unvested restricted stock units, unvested shares of restricted stock and shares of Common Stock gifted to others do not count toward the Target Amount. 
 Executive will be notified on an annual basis of any changes in Executive’s Target Amount. 
 C. Stock Plan Amendments. In accordance with the Agreement dated January 1, 2001 between Executive and the Company, Executive previously
consented, pursuant to Section 14 of the Company’s Second Amended and Restated 1991 Stock Option Plan (the “1991 Plan”), Section 6.2 of the Company’s 1997 Stock Option Plan, as amended (the “1997 Plan”) and
Section 6.2 of the Company’s 1998 Stock Option Plan, as amended (the “1998 Plan,” and together with the 1991 Plan and the 1997 Plan, the “Plans”), that the Plans, as amended by the amendments to the Accelerated
Provisions of the Plans set forth on Exhibit A attached hereto, shall govern and apply to all of Executive’s outstanding options under the Plans, regardless of the date such options were granted. To the extent the option agreements for
Executive’s outstanding options under the Plans state anything to the contrary, Executive and the Company have agreed that such option agreement(s) are amended to be consistent with the foregoing sentence. 
 8. Term of Employment. Executive’s employment with the Company is at the mutual consent of Executive and the Company. Nothing in this
Agreement is intended to guarantee Executive’s continuing employment with the Company or employment for any specific length of time. Accordingly, either Executive or the Company may terminate the employment relationship at any time, with or
without advance notice and with or without cause. Upon termination of Executive’s employment for any reason, in addition to any other payments that may be payable to Executive hereunder, Executive (or Executive’s beneficiaries or estate)
will be paid (in each case to the extent not theretofore paid) within thirty (30) days following Executive’s date of termination, except as provided in Section 9 below, (or such shorter period that may be required by applicable law):
(a) Executive’s annual Base Salary through the date of termination, (b) any compensation previously deferred by Executive (together with any interest and earnings therein), (c) accrued but unused PTO, (d) reimbursable
expenses incurred by Executive prior to the termination date and (e) amounts under any other compensatory plan, arrangement or program payment to which Executive may be entitled. This Agreement constitutes a final and fully binding integrated
agreement with respect to the at-will nature of the employment relationship. 
 9. Termination of Employment/Severance Pay.

 A. Termination Without Cause Not Following Change in Control. If Executive’s employment is terminated by the Company without
Cause at any time that is not within two (2) years after a “Change in Control” (as defined below) of Health Net, Inc., Executive will be entitled to receive, beginning at the end of the first month following the termination of
Executive’s employment, provided Executive signs a Separation Agreement, Waiver and Release of Claims substantially in the form attached hereto as Exhibit B, which is incorporated into this Agreement by reference, a lump sum cash payment equal
to $6,000,000. 
  

 - 6 - 








 For purposes of this Agreement, “Change in Control” is defined as any of
the following which occurs subsequent to the effective date of Executive’s employment: 
 (i) A 51% change in beneficial
ownership as a result of a single transaction of all capital stock of Health Net, Inc.; 
 (ii) A change in the majority of
outside directors of the Health Net, Inc. Board of Directors over two years, which is unapproved by a majority of Health Net, Inc.’s current Board of Directors; 
 (iii) The sale of substantially all of Health Net, Inc.’s assets to an unrelated third party; or 
 (iv) The liquidation or dissolution of Health Net, Inc. 
 B. Termination Without Cause or For Good Reason Following Change in Control. If at any time within two (2) years after a Change in Control of Health Net, Inc. Executive’s employment is terminated by
the Company without cause or Executive terminates Executive’s employment for “Good Reason” (as defined below) (by giving the Company at least fourteen (14) days prior written notice of the effective date of termination), then
Executive will be entitled to receive, beginning at the end of the first month following the termination of Executive’s employment, provided Executive signs a Separation Agreement, Waiver and Release of Claims substantially in the form attached
hereto as Exhibit B, which is incorporated into this Agreement by reference, (i) a lump sum payment equal to $6,000,000, and (ii) Executive’s options that vested prior to the date of Executive’s termination will continue to
remain exercisable for the shorter of, (x) a period of two years following Executive’s date of termination, or (y) the options’ general termination date as set forth in the applicable agreement evidencing the award of such
options. 
 For purposes of this Agreement, the term “Good Reason” means any of the following which occurs, without
Executive’s consent, within two (2) years following the effective date of a Change in Control as defined above: 
 (i) A material reduction in the scope of Executive’s duties, responsibilities, salary or status with the Company; or 
 (ii) A relocation of Executive’s office outside of California; 
 provided, however, that Executive must provide notice to the
Company of the existence of the condition described in Section 9(B)(i) or (ii) within ninety (90) days of the initial existence of the condition, upon the notice of which the Company has thirty (30) days during which it may
remedy the condition, in accordance with Treasury Regulation Section 1.409A-1(n)(2)(ii). 
 C. Voluntary Termination.
Notwithstanding anything to the contrary in this Agreement, whether express or implied, Executive may at any time terminate Executive’s employment for any reason by giving the Company fourteen (14) days prior written notice of the 

  

 - 7 - 








 
effective date of termination. In the event that Executive voluntarily terminates employment with the Company (except for Good Reason within two
(2) years after a Change in Control of Health Net, Inc.), then Executive shall not be eligible to receive any payments or continuation of Benefits set forth in this Section 9). 
 10. Withholding. All payments required to be made by the Company hereunder to Executive or Executive’s estate or beneficiaries shall be
subject to the withholding of such amounts relating to taxes as the Company may reasonably determine should be withheld pursuant to any applicable law or regulation. 
 11. Potential Tax Consequences for “Parachute” Payments. 
 A. Tax Gross-Up.
Notwithstanding any other provisions of this Agreement, in the event that (i) any payment or distribution by the Company to or for Executive’s benefit (whether paid or payable or distributed or distributable pursuant to the terms of this
Agreement or any other plan, arrangement or agreement with the Company, any person whose actions result in a Change in Control or any person affiliated with the Company or such person) (all such payments and distributions, including the severance
payments and benefits provided for in Section 9 hereof (the “Severance Payments”), being hereinafter called (“Total Payments”) would be subject (in whole or part) to the excise tax imposed under Section 4999 of the
Internal Revenue Code of 1986, as amended (the “Code”), or any successor provision enacted under the Code or any interest or penalties are incurred by Executive with respect to such excise tax (such excise tax, together with any such
interest and penalties, are hereinafter collectively referred to as the “Excise Tax”) and (ii) the amount of such Total Payments subject to such Excise Tax exceeds $50,000, then the Company shall pay to Executive an additional cash
payment (the “Tax Gross-Up”) so that after receipt of such Tax Gross-Up, the payment of any additional federal, state and local income taxes on such Tax Gross-Up amount and the payment of any Excise Taxes, Executive shall receive such net
amount of Total Payments equal to the amount that Executive would have received if no Excise Tax was due. If the amount of Total Payments subject to the Excise Tax does not exceed $50,000, then the Tax-Gross-Up shall not be paid and the Severance
Payments shall be reduced (if necessary, to zero) to the extent necessary so that no portion of the Total Payments is subject to the Excise Tax. 
 B. Accounting Firm Determination. All determinations required to be made under this Section 11, including whether and when a Tax Gross-Up is required and the amount of such Tax Gross-Up and the assumptions to be utilized in
arriving at such determination, shall be made by the public accounting firm that, immediately prior to the Change in Control, was the Company’s independent auditor (the “Accounting Firm”) which shall provide detailed supporting
calculations both to the Company and Executive within fifteen (15) business days of the receipt of notice from Executive that Executive has received Total Payments, or such earlier time as is requested by the Company. All fees and expenses of
the Accounting Firm shall be borne solely by the Company. Any Tax Gross-Up, as determined pursuant to this Section 11, shall be paid by the Company to Executive within five (5) days of the receipt of the Accounting Firm’s
determination. If the Accounting Firm determines that no Excise Tax is payable by Executive, then the Accounting Firm shall furnish to Executive a written opinion that failure to report the Excise Tax on Executive’s applicable federal income
tax return would not result in the imposition of any tax assessment or a negligence or similar penalty. As a result of any uncertainty in the application of Section 4999 of the Code at the time of the determination by the 

  

 - 8 - 








 
Accounting Firm hereunder, it is possible that Tax Gross-Up which will not have been made by the Company should have been made (“Underpayment”), or
that amount of the Tax Gross-Up will exceed the amount required under Section 11(A) (“Overpayment”). In the event that the Accounting Firm shall determine that an Underpayment or Overpayment has occurred, either Executive or the
Company, as applicable, shall promptly reimburse the other for the amount of such Underpayment or Overpayment that has occurred. 
 C.
Notifications. Executive shall notify the Company in writing of any claim by the Internal Revenue Service that, if successful, would require the payment by the Company of the Tax Gross-Up. Such notification shall be given as soon as
practicable but no later than ten (10) business days after Executive is informed in writing of such claim and shall apprise the Company of the nature of such claim and the date on which such claim is requested to be paid. Executive and the
Company shall each reasonably cooperate with the other in connection with any administrative or judicial proceedings concerning the existence or amount of liability for Excise Tax with respect to Total Payments. 
 D. Payment Calculator. At the time that payments are made under this Section 11, the Company shall provide Executive with a written statement
setting forth the manner in which such payments were calculated and the basis for such calculations including, without limitation, any opinions or other advice the Company has received from tax counsel, the Accounting Firm or other advisors or
consultants (and any such opinions or advice which are in writing shall be attached to the statement). 
 12. Restrictive Covenants.

 A. Non-Competition. Executive hereby agrees that, during the twelve (12)-month period following a termination of Executive’s
employment with the Company that entitles Executive to receive severance benefits under this Agreement (the “Restricted Period”), Executive shall not undertake any employment or activity with a Competitor (as defined below) in any
geographic area in which the Company or any of its affiliates operate (the “Market Area”), which employment or activity could call upon Executive to reveal, to make judgments on or otherwise use any confidential business information or
trade secrets of the business of the Company or any of its affiliates to which Executive had access during Executive’s employment with the Company. For purposes of this Section, “Competitor” shall refer to Kaiser and its affiliates,
and any publicly traded or mutual health maintenance organization, healthcare management company, physician group, insurance company or similar entity that provides managed health care or related services similar to those provided by the Company or
any of its affiliates in the Market Area. 
 B. Modification of Restrictions. It is hereby further agreed that if any court of
competent jurisdiction shall determine that the restrictions imposed in this Section 12 are unreasonable (including, but not limited to, the definition of Market Area or Competitor or the time period during which this provision is applicable),
the parties hereto hereby agree to any restrictions that such court would find to be reasonable under the circumstances. 
 C. Injunction
Rights. Executive also acknowledges that the services to be rendered by Executive to the Company are of a special and unique character, which gives this Agreement a peculiar value to the Company or any of its affiliates, the loss of which may
not be 

  

 - 9 - 








 
reasonably or adequately compensated for by damages in an action at law, and that a material breach or threatened breach by Executive of any of the
provisions contained in this Section 12 will cause the Company or any of its affiliates irreparable injury. Executive therefore agrees that the Company may be entitled, in addition to the remedies set forth above in this Section 12 and any
other right or remedy, to a temporary, preliminary and permanent injunction, without the necessity of proving the inadequacy of monetary damages or the posting of any bond or security, enjoining or restraining Executive from any such violation or
threatened violations. 
 13. Arbitration. Should disagreements arise with respect to this Agreement, Executive and the Company agree
to submit the matter to binding arbitration. As provided in Section 12 of this Agreement, the Company shall also have the right to pursue an equitable remedy pursuant to the applicable laws of Delaware with respect to the non-compete,
non-solicitation and confidentiality restrictions set forth above. The prevailing party in either the arbitration and/or the equitable remedy action shall recover all attorney’s fees and costs incurred. 
 14. Successors; Binding Agreement. 
 A. Survival Following Merger, Consolidation or Asset Transfer. This Agreement shall not be terminated by any merger or consolidation of the Company whereby the Company is or is not the surviving or resulting corporation or as a
result of any transfer of all or substantially all of the assets of the Company. In the event of any such merger, consolidation or transfer of assets, the provisions of this Agreement shall be binding upon the surviving or resulting corporation or
the person or entity to which such assets are transferred. 
 B. Survivor’s Assumption of Agreement. The Company agrees that
concurrently with any merger, consolidation or transfer of assets referred to in this Section 14, it will cause any successor or transferee to unconditionally assume, by written instrument delivered to Executive (or Executive’s beneficiary
or estate), all of the obligations of the Company hereunder. Failure of the Company to obtain such assumption prior to the effectiveness of any such merger, consolidation or transfer of assets shall entitle Executive to compensation and other
benefits from the Company in the same amount and on the same terms as Executive would be entitled hereunder if Executive’s employment were terminated without Cause. For purposes of implementing the foregoing, the date on which any such merger,
consolidation or transfer becomes effective shall be deemed the date of termination. 
 C. Enforceability. This Agreement shall inure
to the benefit of and be enforceable by Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. If Executive shall die while any amounts would be payable to Executive
hereunder had Executive continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to such person or persons appointed in writing by Executive to receive such amounts or, if no
person is so appointed, to Executive’s estate. 
 15. Section 409A of the Internal Revenue Code. 
 A. It is the intention of the Company and Executive that this Agreement not result in unfavorable tax consequences to Executive under Section 409A of
the Code, and the regulations and guidance promulgated thereunder. All benefits and compensation payable under this Agreement shall be provided in a manner that complies with, or is exempt from, Section 409A. 
  

 - 10 - 








 B. Executive shall be considered to have terminated employment with the Company only when Executive
incurs a “separation from service” with the Company, as defined in Treasury Regulation Section 1.409A-1(h). 
 C. With respect
to the Company’s reimbursement obligations or provision of in-kind benefits under Sections 6(C), 6(E) and 6(H) hereof, or such similar reimbursements or in-kind benefits payable under this Agreement (including the provision of Benefits to
Executive): (i) in no event shall any such reimbursements or in-kind benefits be paid or provided later than the last day of Executive’s taxable year following the taxable year in which the fee or expense was incurred, (ii) the amount
of expenses eligible for reimbursement, or in-kind benefits provided, during Executive’s taxable year may not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year of Executive, and
(iii) the right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit, in accordance with Treasury Regulation Section 1.409A-3(i)(1)(iv). 
 D. Any Tax Gross-Up to be paid by the Company under Section 11 shall be made by the end of Executive’s taxable year next following
Executive’s taxable year in which Executive remits the related taxes. The Tax Gross-Up shall be paid in a manner that complies with Treasury Regulation Section 1.409A-(3)(i)(1)(v). Interest and penalties with respect to any Tax Gross-Up
shall be payable only to the extent permitted under Treasury Regulation Section 1.409A-3(i)(1)(v). To the extent required by Section 409A, any Tax Gross-Up made with respect to any payment that is non-exempt “nonqualified deferred
compensation” (within the meaning of Section 409A) which is subject to Section 409A shall be payable only upon Executive’s Separation from Service and subject to Section 15(E). 
 E. Notwithstanding anything to the contrary herein, if Executive is a “specified employee” (as determined under the Company’s Specified
Employee Policy, or, in the absence of such policy, within the meaning of Section 409A(a)(2)(B)(i)), any non-exempt “nonqualified deferred compensation” amounts (or benefits) that are subject to Section 409A and payable to or in
respect of Executive pursuant to this Agreement shall be delayed until the earliest date permitted by Section 409A(a)(2) of the Code. The Company and Executive agree to cooperate in good faith in an effort to comply with Section 409A of
the Code including, if necessary, amending this Agreement based on further guidance issued by the Internal Revenue Service from time to time, provided that the Company shall not be required to assume any increased economic burden in connection with
such amendment. To the extent payments and benefits under this Agreement are subject to Section 409A, and such payments and benefits do not so comply, the Company shall amend this Agreement, or take such other actions as the Company deems
reasonably necessary or appropriate, to comply with Section 409A. If any provision of the Agreement would cause such payments and benefits to fail to so comply, such provision shall not be effective and shall be null and void with respect to
such payments or benefits, and such provision shall otherwise remain in full force and effect. 
 16. Company Policies.
Executive’s employment with the Company is subject to the terms and conditions contained in the Company’s Associate Policies located on HR Link, which can be accessed through the Company’s intranet site, as in effect from time to time
(the “Associate Policies”), the content of which is incorporated by reference herein. Executive shall be required to read, understand and comply with the Associate Policies. 
  

 - 11 - 








 17. Severability. If any term of this Agreement is held to be invalid, void or unenforceable, the
remainder of this Agreement shall remain in full force and effect and shall in no way be affected and the parties shall use their best efforts to find an alternative way to achieve the same result. 
 18. Integrated Agreement. This Agreement supersedes any prior agreements, representations or promises of any kind, whether written, oral, express
or implied between the parties hereto with respect to the subject matters herein, including, but not limited to, the Prior Employment Agreement. It constitutes the full, complete and exclusive agreement between Executive and the Company with respect
to the subject matters herein. This Agreement cannot be changed unless in writing, signed by Executive and the General Counsel of the Company and approved by the Board . The Company acknowledges and agrees that nothing contained herein shall be
deemed to supercede, amend or otherwise modify the terms of the Indemnification Agreement dated December 17, 2004 between Executive and the Company. 
 19. Waiver. No waiver of any default hereunder shall operate as a waiver of any subsequent default. Failure by either party to enforce any of the terms or conditions of this Agreement, for any length of time or
from time to time, shall not be deemed to waive or decrease the rights of such party to insist thereafter upon strict performance by the other party. 
 20. Notices. All notices and communications required or permitted hereunder shall be in writing and shall be deemed given (a) if delivered personally, (b) one (1) business day after being sent by
Federal Express or a similar commercial overnight service, or (c) three (3) business days after being mailed by registered or certified mail, return receipt requested, prepaid and addressed to the following addresses, or at such other
addresses as the parties may designate by written notice in the manner aforesaid: 
  

			
	If to the Company:	  	Health Net, Inc.
		  	21650 Oxnard Street, 22nd Floor
		  	Woodland Hills, CA 91367
		  	Attention: General Counsel
		
	If to the Executive:	  	Jay M. Gellert
		
		  	
                                        

		
		  	
                                        


 21. Governing Law. The interpretation, construction and performance of this Agreement shall
be governed by and construed and enforced in accordance with the internal laws of the State of Delaware without regard to the principle of conflicts of laws. The invalidity or unenforceability of any provision of this Agreement shall not affect the
validity or enforceability of any other provisions of this Agreement, which other provisions shall remain in full force and effect. 
  

 - 12 - 








 22. Survival and Enforcement. Sections 3, 8, 9, 11, 12, 13 and 14 of this Agreement and any rights
and remedies arising out of this Agreement shall survive and continue in full force and effect in accordance with the respective terms thereof, notwithstanding any termination of this Agreement or Executive’s employment. The parties agree that
the Company would be damaged irreparably in the event any provision of Sections 3, 12 and 14 of this Agreement were not performed in accordance with its terms or were otherwise breached and that money damages would be an inadequate remedy for any
such nonperformance or breach. Therefore, the Company or its successors or assigns shall be entitled in addition to other rights and remedies existing in their favor, to an injunction or injunctions to prevent any breach or threatened breach of any
of such provisions and to enforce such provisions specifically (without posting a bond or other security). 
 23. Acknowledgement.
Executive acknowledges that Executive has had the opportunity to discuss the content of this Agreement with and obtain advice from Executive’s attorney, have had sufficient time to and have carefully read and fully understood all of the
provisions of this Agreement, and Executive is knowingly and voluntarily entering into this Agreement. Executive further acknowledges that Executive is obligated to become familiar with and comply at all times with all written policies of the
Company. 
 [Signature Page to Follow] 
  

 - 13 - 








 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective Date set forth
above. 
  

									
	Executive	 		 	Health Net, Inc.
					
	By:	 	/s/ Jay M. Gellert	 		 	By:	 	/s/ Karin Mayhew
		 	 	 		 		 	 
	Name:	 	Jay M. Gellert	 		 	Name:	 	Karin Mayhew
	Title:	 	President and Chief Executive Officer	 		 	Title:	 	Senior Vice President Organization Effectiveness

  

			
	cc:	  	Linda V. Tiano
		  	Karin Mayhew
		  	Debbie J. Colia/Jay M. Gellert Personnel File








 EXHIBIT A 
 Amendment to Second Amended and Restated 1991 Stock Option Plan 
 The Health Net, Inc. Second Amended and Restated
1991 Stock Option Plan (the “1991 Plan”) is hereby amended to delete paragraph 8 of the 1991 Plan in its entirety and to replace it with the following new paragraph 8: 
 “8. ACCELERATION OF OPTIONS AND RESTRICTED SHARES. 
 Notwithstanding any contrary waiting period
or installment period in any Stock Option Agreement or any Restriction Period in any Restricted Shares Agreement or in the Restated 1991 Plan, each outstanding Option granted under the Restated 1991 Plan shall, except as otherwise provided in the
applicable Stock Option Agreement, become exercisable in full for the aggregate number of shares covered thereby, and each Restricted Share, except as otherwise provided in the Restricted Shares Agreement, shall vest unconditionally, in the event
(i) the Company shall consummate (a) any consolidation or merger of the Company in which the Company is not the continuing or surviving corporation or pursuant to which shares of Common Stock are converted into cash, securities or other
property, other than a Merger, or (b) any sale, lease, exchange, or other transfer (in one transaction or a series of related transactions) of all, or substantially all, of the assets of the Company, or (c) the liquidation or dissolution
of the Company, or (ii) any person (as such term is defined in Sections 13(d)(3) and 14(d)(2) of the Exchange Act), corporation or other entity (other than the Company or any employee benefit plan sponsored by the Company or any Subsidiary)
(A) shall purchase any Common Stock of the Company (or securities convertible into the Company’s Common Stock) for cash, securities or any other consideration pursuant to a tender offer or exchange offer, without the prior consent of the
Board, and (B) shall become the “beneficial owner” (as such term is defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 20 percent or more of the combined voting power of
the then outstanding securities of the Company ordinarily (and apart from rights accruing under special circumstances) having the right to vote in the election of directors (calculated as provided in paragraph (d) of such Rule 13d-3 in the case
of rights to acquire the Company’s securities), or (iii) during any period of two consecutive years, individuals who at the beginning of such period constitute the entire Board shall cease for any reason to constitute a majority thereof
unless the election, or the nomination for election by the Company’s stockholders, of each new director was approved by a vote of at least two-thirds of the directors then still in office who were directors at the beginning of the period, or
(iv) there occurs such other transactions involving a significant issuance of voting stock or change in the composition of the Board that the Board determines to be an accelerating event under this paragraph 8. Any transaction referred to in
the foregoing clause (i) is herein called a Consummated Transaction, any purchase pursuant to a tender offer or exchange offer or otherwise as described in the foregoing clause (ii) is herein called a Control Purchase, the cessation of
individuals constituting a majority of the Board as described in the foregoing clause (iii) is herein called a Board Change and such other transactions as described in the foregoing clause (iv) is herein called an “Other Accelerating
Event”. The Stock Option Agreement and Restricted Shares Agreement evidencing Options or Restricted Shares granted under the Restated 1991 Plan may contain such provisions limiting the acceleration of the exercisability of Options and the
acceleration of the vesting of Restricted Shares as provided in this 

  

 A - 1 








 
paragraph 8 as the Committee deems appropriate to ensure that the penalty provisions of Section 4999 of the Code, or any successor thereto in effect at
the time of such acceleration, will not apply to any stock, cash or other property received by the Holder from the Company.” 
 The 1991
Plan is hereby further amended to delete all references to “Approved Transaction” in the 1991 Plan and to replace all such references with “Consummated Transaction.” 
 Amendment to 1997 Stock Option Plan 
 The Health Net, Inc. 1997 Stock Option Plan (the
“1997 Plan”) is hereby amended to delete subsection 6.8(b) of the 1997 Plan in its entirety and to replace it with the following new subsection 6.8(b): 
 “(b) Definition of Change in Control. A “Change in Control” shall mean: 
 (i) Consummated Transaction.
Consummation of (a) any consolidation or merger of the Company in which the Company is not the continuing or surviving corporation or pursuant to which shares of Common Stock are converted into cash, securities or other property, other than a
Merger, or (b) any sale, lease, exchange, or other transfer (in one transaction or a series of related transactions) of all, or substantially all, of the assets of the Company, or (c) the liquidation or dissolution of the Company;

 (ii) Control Purchase. The purchase by any person (as such term is defined in Sections 13(d)(3) and 14(d)(2) of the Exchange Act),
corporation or other entity (other than the Company or any employee benefit plan sponsored by an Employer) of any Common Stock of the Company (or securities convertible into the Company’s Common Stock) for cash, securities or any other
consideration pursuant to a tender offer or exchange offer, without the prior consent of the Board and, after such purchase, such person shall be the “beneficial owner” (as such term is defined in Rule 13d-3 under the Exchange Act),
directly or indirectly, of securities of the Company representing 20 percent or more of the combined voting power of the then outstanding securities of the Company ordinarily (and apart from rights accruing under special circumstances) having the
right to vote in the election of directors (calculated as provided in Section (d) of such Rule 13d-3 in the case of rights to acquire the Company’s securities); 
 (iii) Board Change. A change in the composition of the Board during any period of two consecutive years, such that individuals who at the beginning of such period constitute the entire Board shall cease for any
reason to constitute a majority thereof unless the election, or the nomination for election by the Company’s stockholders, of each new director was approved by a vote of at least two-thirds of the directors then still in office who were
directors at the beginning of the period; or 
 (iv) Other Transactions. The occurrence of such other transactions involving a
significant issuance of voting stock or change in the composition of the Board that the Board determines to be a Change in Control for purposes of the Plan. 
 The Agreement evidencing options or Restricted Stock granted under the Plan may contain provisions limiting the acceleration of the exercisability of options and the acceleration of the 

  

 A - 2 








 
vesting of Restricted Stock as provided in this Section as the Committee deems appropriate to ensure that the penalty provisions of Section 4999 of the
Code, or any successor thereto in effect at the time of such acceleration, will not apply to any stock, cash or other property received by the holder from the Company.” 
 Amendment to the 1998 Stock Option Plan 
 The Health Net, Inc. 1998 Stock Option Plan, as
amended (the “1998 Plan”), is hereby further amended to delete subsection 6.8(b) of the 1998 Plan in its entirety and to replace it with the following new subsection 6.8(b): 
 “(b) Definition of Change in Control. A “Change in Control” shall mean: 
 (i) Consummated
Transaction. Consummation of (a) any consolidation or merger of the Company in which the Company is not the continuing or surviving corporation or pursuant to which shares of Common Stock are converted into cash, securities or other
property, other than a Merger, or (b) any sale, lease, exchange, or other transfer (in one transaction or a series of related transactions) of all, or substantially all, of the assets of the Company, or (c) the liquidation or dissolution
of the Company; 
 (ii) Control Purchase. The purchase by any person (as such term is defined in Sections 13(d)(3) and 14(d)(2) of the
Exchange Act), corporation or other entity (other than the Company or any employee benefit plan sponsored by an Employer) of any Common Stock of the Company (or securities convertible into the Company’s Common Stock) for cash, securities or any
other consideration pursuant to a tender offer or exchange offer, without the prior consent of the Board and, after such purchase, such person shall be the “beneficial owner” (as such term is defined in Rule 13d-3 under the Exchange Act),
directly or indirectly, of securities of the Company representing 20 percent or more of the combined voting power of the then outstanding securities of the Company ordinarily (and apart from rights accruing under special circumstances) having the
right to vote in the election of directors (calculated as provided in Section (d) of such Rule 13d-3 in the case of rights to acquire the Company’s securities); 
 (iii) Board Change. A change in the composition of the Board during any period of two consecutive years, such that individuals who at the beginning of such period constitute the entire Board shall cease for any
reason to constitute a majority thereof unless the election, or the nomination for election by the Company’s stockholders, of each new director was approved by a vote of at least two-thirds of the directors then still in office who were
directors at the beginning of the period; or 
 (iv) Other Transactions. The occurrence of such other transactions involving a
significant issuance of voting stock or change in the composition of the Board that the Board determines to be a Change in Control for purposes of the Plan. 
 The Agreement evidencing Options or Restricted Stock granted under the Plan may contain such provisions limiting the acceleration of the exercisability of options and the acceleration of the vesting of Restricted
Stock as provided in this Section as the Committee deems appropriate to ensure that the penalty provisions of Section 4999 of the Code, or any successor thereto in effect at the time of such acceleration, will not apply to any stock, cash or
other property received by the holder from the Company.” 
  

 A - 3 








 EXHIBIT B 
 [FORM OF SEPARATION AGREEMENT, WAIVER AND RELEASE OF CLAIMS] 
 This SEPARATION AGREEMENT, WAIVER AND
RELEASE OF CLAIMS (this “Separation Agreement and Release”) is made and entered into as of the dates set forth on the signature pages hereto by and between Health Net, Inc. and its affiliates and subsidiaries (hereinafter referred
to as the “Company”) and [EXECUTIVE NAME] (hereinafter referred to as the “Executive”). 
 WHEREAS,
the Company and Executive are parties to an Employment Agreement dated as of [DATE] (the “Employment Agreement”) and are entering into this Separation Agreement and Release as a condition to Executive’s receipt of a severance
payment thereunder (capitalized terms used but not defined herein shall have the meanings set forth in the Employment Agreement). 
 NOW,
THEREFORE, the Company and Executive agree as follows: 
  

	1.	Executive’s employment with the Company will terminate on [TERM DATE] (the “Termination Date”). Upon termination of employment, Executive will not represent to
anyone that he is an employee of the Company and will not say or do anything purporting to bind the Company. Upon Executive’s termination of employment, Executive shall be deemed to have resigned from all other positions with the Company, if
any, held by Executive. 

  

	2.	Executive’s termination of employment with the Company shall be considered a [DESCRIBE TYPE OF TERMINATION] under the Employment Agreement, and Executive is therefore
eligible to receive [DESCRIBE PAYMENTS AND OTHER BENEFITS TO BE RECEIVED (SEVERANCE, BENEFIT CONTINUATION/COBRA, ETC.]. 

  

	3.	Executive acknowledges that all unused accrued vacation and unused personal absence time will be paid in Executive’s final regular paycheck in keeping with the Company’s
policy and practice or such shorter time as may be required by applicable law. Executive further acknowledges that no further vacation/paid-time-off or other benefits will accrue after the Termination Date. 

  

	4.	Executive’s participation in all Company employee benefit plans as an active employee shall cease on the Termination Date, and Executive shall not be eligible to make
contributions to or to receive Company matching contributions under the Health Net, Inc. 401(k) Associate Savings Plan, or to make any deferrals pursuant to any deferred compensation plan of the Company after the Termination Date (it being
understood that Executive shall be entitled to all vested benefits accrued as of the date hereof under the Company’s 401(k) Savings Plan and any deferred compensation plan). If, immediately prior to the Termination Date, Executive participates
in any Company employee welfare benefit plan, Executive’s participation in such plan shall continue on the same terms and conditions, including the same co-payment terms, until 11:59 p.m. (Pacific Time) on the last day of the month in which the
Termination Date occurs. 

  

 B - 1 









	5.	In partial consideration of the Company providing Executive the payments and benefits set forth above and as a condition to receive such payments and benefits, which Executive
acknowledges he is not otherwise entitled to receive, Executive freely and voluntarily enters into this Separation Agreement and Release and, by signing this Separation Agreement and Release, Executive, on his own behalf and on behalf of his heirs,
beneficiaries, successors, representatives, trustees, administrators and assigns, hereby waives and releases the Company, and each of its past, present and future officers, directors, shareholders, employees, consultants, accountants, attorneys,
agents, managers, insurers, sureties, parent and sister corporations, divisions, subsidiary corporations and entities, partners, joint venturers, affiliates, beneficiaries, successors, representatives and assigns, from any and all claims, demands,
damages, debts, liabilities, controversies, obligations, actions or causes of action of any nature whatsoever, whether based on tort, statute, contract, indemnity, rescission or any other theory of recovery, including but not limited to claims
arising under federal, state or local laws prohibiting discrimination in employment, including Title VII of the Civil Rights Act of 1964, as amended, the Civil Rights Act of 1870, as amended, claims of disability discrimination under the Americans
with Disabilities Act, the Age Discrimination in Employment Act, as amended (“ADEA”), the Worker Adjustment and Retraining Notification Act (“WARN”), or claims growing out of any legal restrictions on the
Company’s right to terminate its employees and whether for compensatory, punitive, equitable or other relief, whether known, unknown, suspected or unsuspected, against the Company, including without limitation claims which may have arisen or
may in the future arise in connection with any event which occurred on or before the date of Executive’s execution of this Separation Agreement and Release. The provisions in this paragraph do not extend to any rights Executive may have to
enforce the terms of this Agreement and are not intended to prohibit Executive from filing a claim for unemployment insurance. 

  

	6.	Executive expressly waives any right or claim of right to assert hereafter that any claim, demand, obligation and/or cause of action has, through ignorance, oversight or error, been
omitted from the terms of this Separation Agreement and Release. Executive makes this waiver with full knowledge of his rights and with specific intent to release both his known and unknown claims, and therefore specifically waives the provisions of
Section 1542 of the Civil Code of California or other similar provisions of any other applicable law, which reads as follows: 

 “A general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the
debtor.” 
 Executive understands and acknowledges the significance and consequence of this Separation Agreement and Release and of such
specific waiver of Section 1542, and expressly agrees that this Agreement shall be given full force and effect according to each and all of its express terms and provisions, including those relating to unknown and unsuspected claims, demands,
obligations and causes of action herein above specified. 
  

 B - 2 









	7.	Executive shall not initiate or cause to be initiated against the Company any compliance review, suit, action, investigation or proceeding of any kind, or voluntarily participate in
same, individually or as a representative, witness or member of a class, under contract, law or regulation, federal, state or local, pertaining to any matter related to his employment with the Company, unless Executive first cooperates in making his
allegations known to the Company for the Company to take corrective action at a time and place designated by the Company. Executive represents and warrants that he has not, to date, initiated (or caused to be initiated) any such review, suit,
action, investigation or proceeding; provided, however, that nothing in this Section 7 shall restrict Executive’s ability to challenge the validity of any release herein of ADEA claims nor to any suit or action brought by
Executive to assert such a challenge. In addition, Executive shall, without further compensation, cooperate with and assist the Company in the investigation of, preparation for or defense of any actual or threatened third party claim, investigation
or proceeding involving the Company or its predecessors or affiliates and arising from or relating to, in whole or in part, Executive’s employment with the Company or its predecessors or affiliates for which the Company requests
Executive’s assistance, which cooperation and assistance shall include, but not be limited to, providing testimony and assisting in information and document gathering efforts. In this connection, it is agreed that the Company will use its
reasonable best efforts to assure that any request for such cooperation will not unduly interfere with Executive’s other material business and personal obligations and commitments. 

  

	8.	Executive agrees he will return to the Company immediately upon termination any building keys, security passes or other access or identification cards and any Company property that
was in his possession, including but not limited to any documents, credit cards, computer equipment, mobile phones or data files. Executive agrees to clear all expense accounts and pay all amounts owed on any corporate credit cards which the Company
previously issued to Executive, subject to the Company’s obligation to reimburse Executive for any properly reimbursable business expenses in accordance with the Company’s expense policies and procedures then in effect.


  

	9.	Executive shall not, without the Company’s written consent by an authorized representative, at any time prior or subsequent to the execution of this Separation Agreement and
Release, disclose, use, remove or copy any confidential, trade secret or proprietary information he acquired during the course of his employment by the Company, including without limitation, any technical, actuarial, economic, financial,
procurement, provider, customer, underwriting, contractual, managerial, marketing or other information of any type that has economic value in the business in which the Company is engaged, but not including any previously published information or
other information generally in the public domain. 

  

	10.	 In addition to any other part or term of this Separation Agreement and Release or the Employment Agreement, Executive agrees that he will not, (a) [a period
of one (1) year] [the six (6) month period] for a period of one (1) year from the date of this Agreement, irrespective of the reason for the termination, either directly or indirectly, on his own behalf or on behalf of any other
person: (1) make known to any person, firm, corporation or other entity of any type, the names and addresses of any of the Company’s customers, 



  

 B - 3 









	 	 
enrollees or providers or any other information pertaining to them; or (2) disrupt, solicit or influence or attempt to solicit, disrupt or influence any
of the Company’s customers, providers, vendors, agents or independent contractors with whom the Executive became acquainted during the course of employment or service for the purpose of terminating such a person’s or entity’s
relationship with the Company or causing such a person or entity to associate with a competitor of the Company, and (b) [a period of one (1) year] [the six (6) month period] following the Termination Date undertake any
employment or activity prohibited by the Employment Agreement. The prohibitions of this paragraph are not intended to deny employment opportunities within the Executive’s field of employment but are limited only to those prohibitions necessary
to protect the Company from unfair competition. In addition, Executive agrees that, for [a period of one (1) year] [the six (6) month period] following the Termination Date, he shall not, directly or indirectly solicit, interfere
with, hire, offer to hire or induce any person, who is or was an employee of the Company or any of its affiliates at the time of such solicitation, interference, hiring, offering to hire or inducement, to discontinue his/her relationship with the
Company or any of its affiliates or to accept employment by, or enter into a business relationship with, Executive or any other entity or person. 


  

	11.	Executive further agrees that, in exchange for the consideration set forth in Section 2 hereof, Executive shall not make any disparaging comments and/or statements to anyone
either orally or in writing about the Company and/or its employees. 

  

	12.	Nothing contained herein shall be construed as an admission of any wrongful act, including but not limited to violation of any contract, express or implied, or any federal, state or
local employment laws or regulations, and nothing contained herein shall be used for any purpose except in proceedings related to the enforcement of this Separation Agreement and Release. 

  

	13.	If any part or term of this Separation Agreement and Release is held invalid or unenforceable by any court or arbitrator, such invalidity or unenforceability shall not affect in any
way the validity or enforceability of any other part or term of this Separation Agreement and Release. In addition, if any court of competent jurisdiction construes the covenants contained in Section 10 hereof, or any part thereof, to be
unenforceable in any respect, the court may reduce the duration or scope to the extent necessary so that the provision is enforceable, and the provision, as reduced, shall then be enforceable. 

  

	14.	Executive agrees and acknowledges that this Separation Agreement and Release recites all payments and benefits Executive is entitled to receive hereunder and under the Employment
Agreement, and that no other payments or benefits will be asserted or requested by Executive. 

  

	15.	 The Executive acknowledges that he has had an opportunity to consult and be represented by counsel of his own choosing in the review of this Separation Agreement
and Release, and that he has been advised by the Company to do so, that the Executive is fully aware of this Separation Agreement and Release and of its legal effect, that the preceding paragraphs recite the sole consideration for this Separation
Agreement and Release, and that Executive enters into this Separation Agreement and Release freely, without coercion, and based on the Executive’s own judgment and not in reliance upon any 



  

 B - 4 









	 	 
representation or promise made by the other party, other than those contained herein. There may be no modification of the terms of this Separation Agreement
and Release except in writing signed by the parties hereto including an appropriately authorized officer of the Company. 


  

	16.	This Separation Agreement and Release constitutes the full, complete and exclusive agreement between Executive and the Company with respect to the subject matters herein and
supersedes any prior agreements, representations or promises of any kind, whether written, oral, express or implied, with respect to the subject matters herein. This Separation Agreement and Release cannot be changed unless in writing, signed by
Executive and an authorized officer of the Company. 

  

	17.	If there is any dispute between the Company and Executive over the terms or obligations under this Separation Agreement and Release, that dispute shall be resolved by binding
arbitration before a single neutral arbitrator who shall be a retired judge. The arbitration shall proceed in accordance with the then-current rules of the Commercial American Arbitration Association to the extent not inconsistent with this
Separation Agreement and Release. The judgment of the arbitrator shall be final, binding and nonappealable, and may be entered in any state or federal court having jurisdiction thereafter. The arbitrator shall be bound to apply and follow the
applicable state or federal laws in reaching a decision in this matter. Any disagreement regarding whether a dispute is required to be arbitrated pursuant to this Separation Agreement and Release shall be decided by the arbitrator. The Federal
Arbitration Act, 9 U.S.C. Sections 1-16, shall govern the interpretation and enforcement of this Section 17. The prevailing party will be entitled to recover reasonable attorney’s fees and costs incurred in any action to enforce or defend
this Separation Agreement and Release. 

  

	18.	This Separation Agreement and Release shall be construed and governed by the laws of the State of Delaware. 

 EXECUTIVE ACKNOWLEDGES BY SIGNING BELOW that (i) Executive has not relied upon any representations, written or oral, not set forth in this
Separation Agreement and Release; (ii) at the time Executive was given this Separation Agreement and Release Executive was informed in writing by the Company that (a) Executive had at least 21 days in which to consider whether Executive
would sign the Separation Agreement and Release and (b) Executive should consult with an attorney before signing the Separation Agreement and Release; and (iii) Executive had an opportunity to consult with an attorney and either had such
consultations or has freely decided to sign this Separation Agreement and Release without consulting an attorney. 
 Executive further
acknowledges that he may revoke acceptance of this Separation Agreement and Release by delivering a letter of revocation within seven (7) days after the later of the dates set forth below addressed to: Health Net, Inc., Organization
Effectiveness Department, 21650 Oxnard Street, Woodland Hills, California 91367, Attention: Karin Mayhew. 
 Finally, Executive acknowledges
that he understands that this Separation Agreement and Release will not become effective until the eighth (8th) day following his signing this Separation Agreement and Release and that if Executive does not revoke his acceptance of the terms of
this Separation Agreement and Release within the seven (7) day period following the date on which Executive signs this Separation Agreement and Release as set forth above, this Separation Agreement and Release will be binding and enforceable.

 [Signature Page Follows] 
  

 B - 5 








 IN WITNESS WHEREOF, the parties hereto have executed this Separation Agreement and Release as of the
dates set forth below. 
  

									
	Executive	 		 	Health Net, Inc.
					
	By:	 	 [EXHIBIT COPY]
	 		 	By:	 	 [EXHIBIT COPY]

	Name:	 		 		 	Name:	 	
	Title:	 		 		 	Title:	 	
	Dated:	 	 [TO BE INSERTED]
	 		 	Dated:	 	 [TO BE INSERTED]


  

 B - 6